Omega Healthcare Investors, Inc. (NYSE:OHI) Shares Purchased by Franklin Resources Inc.

Franklin Resources Inc. lifted its holdings in shares of Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) by 441.4% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 429,993 shares of the real estate investment trust's stock after purchasing an additional 350,570 shares during the quarter. Franklin Resources Inc. owned 0.16% of Omega Healthcare Investors worth $17,177,000 at the end of the most recent quarter.

Several other hedge funds have also bought and sold shares of OHI. Geode Capital Management LLC increased its holdings in shares of Omega Healthcare Investors by 3.1% in the third quarter. Geode Capital Management LLC now owns 6,426,129 shares of the real estate investment trust's stock worth $261,589,000 after buying an additional 192,465 shares during the period. State Street Corp increased its stake in Omega Healthcare Investors by 0.9% in the 3rd quarter. State Street Corp now owns 12,339,753 shares of the real estate investment trust's stock worth $502,228,000 after purchasing an additional 114,085 shares during the period. Assetmark Inc. lifted its position in Omega Healthcare Investors by 1.7% in the third quarter. Assetmark Inc. now owns 1,191,460 shares of the real estate investment trust's stock valued at $48,492,000 after purchasing an additional 19,542 shares during the last quarter. BNP Paribas Financial Markets boosted its stake in shares of Omega Healthcare Investors by 120.8% during the third quarter. BNP Paribas Financial Markets now owns 226,338 shares of the real estate investment trust's stock valued at $9,212,000 after purchasing an additional 123,836 shares during the period. Finally, Daiwa Securities Group Inc. grew its holdings in shares of Omega Healthcare Investors by 317.7% in the third quarter. Daiwa Securities Group Inc. now owns 3,949,368 shares of the real estate investment trust's stock worth $160,739,000 after purchasing an additional 3,003,845 shares during the last quarter. 65.25% of the stock is currently owned by institutional investors.

Omega Healthcare Investors Price Performance

NYSE:OHI opened at $37.83 on Friday. The company has a market capitalization of $10.21 billion, a P/E ratio of 27.82, a P/E/G ratio of 1.22 and a beta of 0.98. The business's 50-day moving average is $40.26 and its 200 day moving average is $38.11. The company has a current ratio of 6.48, a quick ratio of 6.48 and a debt-to-equity ratio of 1.10. Omega Healthcare Investors, Inc. has a 12 month low of $27.53 and a 12 month high of $44.42.

Omega Healthcare Investors Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Monday, November 4th were given a dividend of $0.67 per share. The ex-dividend date was Monday, November 4th. This represents a $2.68 annualized dividend and a yield of 7.08%. Omega Healthcare Investors's dividend payout ratio (DPR) is currently 197.06%.

Insider Activity at Omega Healthcare Investors

In related news, CFO Robert O. Stephenson sold 22,542 shares of the company's stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.19, for a total value of $905,962.98. Following the completion of the sale, the chief financial officer now directly owns 183,076 shares of the company's stock, valued at $7,357,824.44. This represents a 10.96 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, COO Daniel J. Booth sold 56,725 shares of the business's stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the completion of the sale, the chief operating officer now owns 100,000 shares of the company's stock, valued at approximately $4,025,000. This represents a 36.19 % decrease in their position. The disclosure for this sale can be found here. 1.37% of the stock is owned by insiders.

Analyst Ratings Changes

OHI has been the subject of several recent analyst reports. Royal Bank of Canada upped their price objective on shares of Omega Healthcare Investors from $39.00 to $43.00 and gave the company a "sector perform" rating in a research note on Monday, November 11th. Scotiabank raised their price target on Omega Healthcare Investors from $33.00 to $39.00 and gave the company a "sector perform" rating in a report on Monday, August 26th. Wells Fargo & Company reiterated an "overweight" rating and issued a $43.00 price target (up previously from $40.00) on shares of Omega Healthcare Investors in a research note on Tuesday, October 1st. BNP Paribas upgraded shares of Omega Healthcare Investors from a "neutral" rating to an "outperform" rating and set a $49.00 price objective for the company in a research note on Thursday, October 31st. Finally, Truist Financial raised their price target on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the company a "hold" rating in a research report on Wednesday, September 4th. Six investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $40.18.

Omega Healthcare Investors Company Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.